Today the Pancreatic Cancer Action Network announced Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer by tailoring their treatment to their cancer's unique molecular profile. Fred Hutchinson Cancer Research Center will play a major role in the effort; it has been selected to lead one of the 12 initial clinical trial sites equipped to provide treatment to pancreatic cancer patients under the new initiative.
UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
The White House and the National Institutes of Health (NIH) have announced Baylor Scott & White Research Institute is joining a five-member research consortium to expand precision medicine research.
Officials of the National Cancer Institute joined cancer scientists on Monday to announce the launch of three ambitious clinical trials designed to bolster research undergirding President Obama's precision medicine initiative.
Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a...